PERCEPTIVE ADVISORS LLC
NEW YORK, NY · CIK 1224962 · 13F filing filed 2024-08-16
SEC-registered investment adviser since 2010 · limited liability company
- Assets managed$11.8bn
- Staff49 · 28 in investment roles
- Main clients (by assets)Private funds 99%
- Private funds17 (6 hedge) · $11.7bn gross assets
- Form ADV · 2026-07-13SEC adviser record
- Legal entityPERCEPTIVE ADVISORS LLC (US)
- Kindhedge funds, private equity, venture, futures
- Others nearbyNew York, NY, Greenwich, CT, Miami Beach, FL, Sheridan, WY, Water Mill, NY
As an employer
- Offices in1 country
- Private fundshedge 6, venture capital 2, private equity 5, other private 4
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 25 |
| Greenwich, CTUnited States | 1 |
| Miami Beach, FLUnited States | 1 |
| Sheridan, WYUnited States | 1 |
| Water Mill, NYUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 1 call positions ($5.3m notional), 2 put positions ($3.5m notional) – listed below, not included above.
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CEREVEL THERAPEUTICS HLDNG I CERE | $441.4m10.65% | Unchanged |
| AMICUS THERAPEUTICS INC FOLD | $278.3m6.72% | Unchanged |
| ARCELLX INC ACLX | $214.7m5.18% | Reduced -43.8k |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $208.0m5.02% | Added +6.7m |
| NUVALENT INC COM | $193.4m4.67% | Reduced -234.4k |
| RHYTHM PHARMACEUTICALS INC RYTM | $141.5m3.42% | Added +178.0k |
| VAXCYTE INC PCVX | $140.6m3.39% | Reduced -70.2k |
| SOLENO THERAPEUTICS INC SLNO | $130.8m3.16% | Added +130.4k |
| INTRA-CELLULAR THERAPIES INC ITCI | $117.6m2.84% | Added +661.1k |
| IMMATICS N.V IMTX | $94.0m2.27% | Added +3.5m |
| NEUROCRINE BIOSCIENCES INC NBIX | $89.5m2.16% | Reduced -154.5k |
| APOGEE THERAPEUTICS INC COM | $82.9m2.00% | Added +45.2k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $74.1m1.79% | Reduced -165.4k |
| ARTIVION INC AORT | $71.7m1.73% | Added +124.7k |
| SPYRE THERAPEUTICS INC SYRE | $71.3m1.72% | Added +474.3k |
| CRINETICS PHARMACEUTICALS IN CRNX | $66.1m1.60% | Unchanged |
| EVOLUS INC EOLS | $62.4m1.51% | Unchanged |
| SPRINGWORKS THERAPEUTICS INC SWTX | $62.3m1.50% | Reduced -609.5k |
| CARGO THERAPEUTICS INC COM | $60.5m1.46% | Added +235.0k |
| ASTRIA THERAPEUTICS INC CATB | $59.0m1.42% | Unchanged |
| NATERA INC NTRA | $57.4m1.39% | Reduced -227.2k |
| VERRICA PHARMACEUTICALS INC COM | $51.8m1.25% | Unchanged |
| BIOHAVEN LTD BHVN | $51.6m1.24% | Reduced -239.8k |
| IMMUNOVANT INC IMVT | $50.8m1.23% | Reduced -1.0m |
| MEIRAGTX HLDGS PLC MGTX | $47.7m1.15% | Unchanged |
| PROTAGONIST THERAPEUTICS INC PTGX | $44.0m1.06% | Added +274.4k |
| SOLID BIOSCIENCES INC SLDB | $39.2m0.95% | Unchanged |
| CELCUITY INC CELC | $38.7m0.93% | Unchanged |
| MEDTRONIC PLC MDT | $38.6m0.93% | Reduced -938.9k |
| VIKING THERAPEUTICS INC VKTX | $38.2m0.92% | Reduced -272.7k |
| APPLIED THERAPEUTICS INC APLT | $37.4m0.90% | Unchanged |
| AXSOME THERAPEUTICS INC AXSM | $37.0m0.89% | Reduced -646.2k |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $35.5m0.86% | Added +850.0k |
| TARSUS PHARMACEUTICALS INC TARS | $35.2m0.85% | Unchanged |
| VERONA PHARMA PLC VRNA | $35.2m0.85% | Reduced -1.3m |
| AKERO THERAPEUTICS INC AKRO | $35.2m0.85% | Added +112.4k |
| EDGEWISE THERAPEUTICS INC EWTX | $33.4m0.81% | Reduced -463.2k |
| ACRIVON THERAPEUTICS INC ACRV | $31.1m0.75% | Added +2.4m |
| PRAXIS PRECISION MEDICINES I PRAX | $31.0m0.75% | Reduced -71.4k |
| ADMA BIOLOGICS INC ADMA | $31.0m0.75% | Reduced -3.7m |
| BRIDGEBIO PHARMA INC BBIO | $30.8m0.74% | Reduced -196.7k |
| ALDEYRA THERAPEUTICS INC ALDX | $30.7m0.74% | Added +682.3k |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $29.5m0.71% | Unchanged |
| CONTINEUM THERAPEUTICS INC CTNM | $27.6m0.67% | New |
| INTUITIVE SURGICAL INC ISRG | $27.5m0.66% | Reduced -40.0k |
| ARVINAS INC ARVN | $27.4m0.66% | Reduced -208.9k |
| ROCKET PHARMACEUTICALS INC RCKT | $26.8m0.65% | Reduced -554.5k |
| DISC MEDICINE INC IRON | $24.9m0.60% | Reduced -386.4k |
| LIVANOVA PLC LIVN | $24.3m0.59% | Added +145.0k |
| CG ONCOLOGY INC CGON | $23.2m0.56% | Reduced -570.4k |
| XENON PHARMACEUTICALS INC XENE | $22.7m0.55% | Reduced -309.0k |
| OCULAR THERAPEUTIX INC OCUL | $22.7m0.55% | Unchanged |
| PEPGEN INC PEPG | $22.5m0.54% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $21.2m0.51% | Reduced -2.0m |
| ORCHESTRA BIOMED HLDGS INC OBIO | $20.7m0.50% | Unchanged |
| MERUS N V MRUS | $17.8m0.43% | New |
| RAPPORT THERAPEUTICS INC RAPP | $17.4m0.42% | New |
| TYRA BIOSCIENCES INC TYRA | $16.1m0.39% | Added +338.2k |
| INHIBRX BIOSCIENCES INC INBX | $15.1m0.36% | New |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $14.5m0.35% | Added +808.5k |
| ATHIRA PHARMA INC COM | $14.3m0.35% | Unchanged |
| ZYMEWORKS INC ZYME | $14.2m0.34% | Added +592.9k |
| CULLINAN THERAPEUTICS INC CGEM | $13.1m0.32% | New |
| PROCEPT BIOROBOTICS CORP PRCT | $12.9m0.31% | Unchanged |
| INSMED INC INSM | $12.1m0.29% | New |
| BICYCLE THERAPEUTICS PLC BCYC | $11.6m0.28% | New |
| ICON PLC ICLR | $9.8m0.24% | New |
| TEMPUS AI INC TEM | $9.6m0.23% | New |
| ARRIVENT BIOPHARMA INC AVBP | $7.7m0.19% | Unchanged |
| ENGENE HOLDINGS INC COM | $7.5m0.18% | Reduced -198.9k |
| ARS PHARMACEUTICALS INC SPRY | $7.4m0.18% | Unchanged |
| ARGENX SE ARGX | $6.7m0.16% | New |
| ALLOGENE THERAPEUTICS INC ALLO | $6.3m0.15% | New |
| VERU INC COM | $5.9m0.14% | Added +1.5m |
| KALVISTA PHARMACEUTICALS INC KALV | $5.9m0.14% | Unchanged |
| RECURSION PHARMACEUTICALS IN RXRX | $5.8m0.14% | New |
| EYEPOINT PHARMACEUTICALS INC EYPT | $5.6m0.13% | Added +50.6k |
| HELIX ACQUISITION CORP II BBOT | $5.1m0.12% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $4.5m0.11% | New |
| CABALETTA BIO INC CABA | $4.4m0.11% | Reduced -1.1m |
| PRECISION BIOSCIENCES INC DTIL | $4.1m0.10% | Reduced -54.2k |
| SKYE BIOSCIENCE INC COM NEW | $4.0m0.10% | New |
| TRINITY BIOTECH PLC SPONS ADR NEW | $3.8m0.09% | Unchanged |
| IRHYTHM TECHNOLOGIES INC IRTC | $3.8m0.09% | Reduced -210.0k |
| LYRA THERAPEUTICS INC LYRA | $3.5m0.09% | Unchanged |
| BIODESIX INC COM | $3.3m0.08% | New |
| ENVVENO MEDICAL CORPORATION COM | $3.3m0.08% | Unchanged |
| FOGHORN THERAPEUTICS INC FHTX | $3.1m0.08% | New |
| NANOBIOTIX NBTX | $2.8m0.07% | Unchanged |
| ABSCI CORPORATION ABSI | $2.2m0.05% | Unchanged |
| SPDR SER TR XBI | $2.1m0.05% | New |
| X4 PHARMACEUTICALS INC COM | $2.1m0.05% | Unchanged |
| FORTE BIOSCIENCES INC COM | $1.8m0.04% | Unchanged |
| REVANCE THERAPEUTICS INC RVNC | $1.5m0.04% | Unchanged |
| STRUCTURE THERAPEUTICS INC GPCR | $1.4m0.03% | New |
| FATE THERAPEUTICS INC FATE | $1.1m0.03% | New |
| KYVERNA THERAPEUTICS INC KYTX | $1.1m0.03% | Unchanged |
| EAGLE PHARMACEUTICALS INC EGRX | $970.8k0.02% | New |
| VBI VACCINES INC CDA VAC | $832.7k0.02% | Unchanged |
| TACTILE SYS TECHNOLOGY INC TCMD | $747.9k0.02% | Reduced -840.4k |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| INHIBRX INC INBX | $148.8m4.3m shares |
| FUSION PHARMACEUTICALS INC | $145.5m6.8m shares |
| SAREPTA THERAPEUTICS INC SRPT | $68.1m525.7k shares |
| LANDOS BIOPHARMA INC | $31.9m1.5m shares |
| TREACE MED CONCEPTS INC TMCI | $30.1m2.3m shares |
| AUTOLUS THERAPEUTICS PLC AUTL | $27.6m4.3m shares |
| REVOLUTION MEDICINES INC RVMD | $19.9m618.9k shares |
| ABBVIE INC ABBV | $19.4m106.5k shares |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $17.0m339.0k shares |
| RAPT THERAPEUTICS INC | $11.0m1.2m shares |
| MORPHIC HLDG INC MORF | $10.1m288.2k shares |
| COGENT BIOSCIENCES INC COGT | $5.9m883.3k shares |
| IMMUNITYBIO INC IBRX | $5.7m1.1m shares |
| MACROGENICS INC MGNX | $5.6m378.3k shares |
| ESTABLISHMENT LABS HLDGS INC ESTA | $4.2m82.3k shares |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $4.1m175.0k shares |
| SINGULAR GENOMICS SYSTEMS IN | $1.1m2.1m shares |
| KURA ONCOLOGY INC KURA | $1.0m48.2k shares |
| AMYLYX PHARMACEUTICALS INC AMLX | $852.0k300.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| IMMUNOVANT INC IMVT · Call | $5.3m200.0k shares | Added |
| CASSAVA SCIENCES INC FLNA · Put | $2.3m183.0k shares | New |
| NOVAVAX INC NVAX · Put | $1.3m100.0k shares | Reduced |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.
| Company | Stake |
|---|---|
| ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 | 55.4%≈ $8.8m |
| LEONABIO INC LONA · 13D · filed 2026-10-26 | 20.0%≈ $17.4m |
| LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 | 15.6% |
| MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 | 12.6%≈ $158.6m |
| SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 | 11.2%≈ $120.3m |
| PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 | 10.1% |
| INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 | 10.0%≈ $141.1m |
| ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 | 10.0%≈ $110.2m |
| OPUS GENETICS INC IRD · 13G · filed 2026-08-14 | 10.0%≈ $37.6m |
| ENGENE HOLDINGS INC 13G · filed 2026-08-14 | 10.0% |
| KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 | 10.0%≈ $1.2m |
| ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 | 10.0% |
| ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 | 10.0%≈ $24.5m |
| TRINITY BIOTECH PLC 13D · filed 2026-05-04 | 9.9% |
| OUTSET MED INC OM · 13G · filed 2025-02-28 | 9.5% |
| NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 | 9.1%≈ $21.8m |
| KARDIGAN INC KARD · 13D · filed 2026-10-01 | 8.8%≈ $196.9m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 | 8.4%≈ $1.7m |
| RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 | 8.2%≈ $8.0m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.1%≈ $37.8m |
| SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 | 7.9%≈ $43.3m |
| PALISADE BIO INC PALI · 13G · filed 2026-05-15 | 7.9%≈ $29.5m |
| IMMATICS N.V IMTX · 13D · filed 2026-08-27 | 7.6%≈ $113.5m |
| AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 | 7.5%≈ $148.8m |
| SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 | 7.3%≈ $25.8m |
Trades reported as a company insider in Q2 2024
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2024-04-11 | ACRIVON THERAPEUTICS INC 10% owner · See Footnote | Bought | $20.0m2.4m shares |
| 2024-04-05 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $178.8k37.7k shares |
| 2024-04-04 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $655.1k140.3k shares |
| 2024-04-03 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $1.3m309.8k shares |
| 2024-04-02 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $640.0k186.1k shares |
| 2024-04-01 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $27.2k8.4k shares |